HealthManagement, Volume 1 - Issue 1, November-December 2007
CardioDynamics International has reported that it is progressing with its shareholders’ approval for the sale of its Vermed business unit. The company reached an agreement to sell the Vermed unit to the subsidiary's management team for a cash purchase price of $8 million in late June this year. Vermed is a supplier of disposable electrodes and related supplies utilised in electrocardiograph (ECG) and other diagnostic procedures. CardioDynamics said the decision to sell Vermed will allow it to focus its resources on its proprietary ICG business, which it believes continues to hold the highest growth potential, while maintaining a long-term preferential relationship with Vermed for ICG sensors.
